Successful and Rapid Reduction in Neurosedative and Analgesic Medications in Complex Infants with Severe Bronchopulmonary Dysplasia After Tracheostomy Placement: Experience with 24-hour Propofol Infusions.

Autor: Hannan KE; Section of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. Electronic address: Kathleen.Hannan@childrenscolorado.org., Bourque SL; Section of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO., Ross E; Section of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO., Wymore EM; Section of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO., Kinsella JP; Section of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO., Mandell EW; Section of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO., Houin SS; Section of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO.
Jazyk: angličtina
Zdroj: The Journal of pediatrics [J Pediatr] 2024 Jul; Vol. 270, pp. 114040. Date of Electronic Publication: 2024 Mar 28.
DOI: 10.1016/j.jpeds.2024.114040
Abstrakt: Infants with severe bronchopulmonary dysplasia may require high doses of neurosedative medications to ensure pain control and stability following tracheostomy placement. Subsequent weaning of these medications safely and rapidly is a challenge. We describe a 24-hour propofol infusion to reduce neurosedative medications in 3 high-risk infants following tracheostomy placement.
Competing Interests: Declaration of Competing Interest The authors have no conflicts of interest to disclose.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: